Pay in 4 interest-free payments of $7.17 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
The first Australian evidence-based guidelines on male infertility
Glucose-dependent Insulinotropic Polypeptide stimulates Osteopontin expression in the vasculature via Endothelin-1 and CREB
Merck may argue that Januvia and Janumet are unavoidably unsafe products and therefore the burden is on the patient to use the drugs cautiously
A doctor or other trusted healthcare professional can help determine whether a GLP-1 agonist may be beneficial for you, depending on your health concerns and goals
Contact your GP or healthcare provider if you experience: Palpitations : Awareness of rapid, forceful, or irregular heartbeat, particularly if persistent or distressing Chest discomfort : Any chest pain, pressure, or tightness, especially with exertion Breathlessness : Unusual shortness of breath, particularly if worsening or occurring at rest Dizziness or lightheadedness : Especially if associated with near-fainting episodes Fatigue : Marked, unexplained tiredness that interferes with daily activities Persistent vomiting or diarrhoea : Which could lead to dehydration and kidney problems If you're unsure whether you need urgent care and cannot contact your GP, call NHS 111
The American Diabetes Association recommends reassessing glycemic control within 3 months of any significant medication change
